Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
NLI Holdings
NL
$312M
| $971K | ﹤0.01% |
142,698
+1,948
| +1% | +$14.5K |
|
3352
Akebia Therapeutics
AKBA
$245M
| $970K | ﹤0.01% |
1,682,498
+60,673
| +4% | +$19K |
|
|
TCN
3353
DELISTED
Tricon Residential Inc.
TCN
| $966K | ﹤0.01% |
125,377
+944
| +0.8% | +$7.88K |
|
3354
AEye
LIDR
$58.8M
| $965K | ﹤0.01% |
66,960
+22,150
| +49% | +$575K |
|
3355
CytomX Therapeutics
CTMX
$752M
| $964K | ﹤0.01% |
603,075
+15,624
| +3% | +$23.1K |
|
|
NBIS
3356
Nebius Group N.V.
NBIS
$48.7B
| $961K | ﹤0.01% |
280,281
| – | – |
|
|
OPTN
3357
DELISTED
OptiNose
OPTN
| $960K | ﹤0.01% |
34,621
-69
| -0.2% | -$2.62K |
|
3358
First United
FUNC
$286M
| $958K | ﹤0.01% |
48,791
+612
| +1% | +$11.5K |
|
3359
Comscore
SCOR
$113M
| $958K | ﹤0.01% |
41,308
+346
| +0.8% | +$8.97K |
|
3360
Tenaya Therapeutics
TNYA
$165M
| $956K | ﹤0.01% |
475,744
+25,836
| +6% | +$63.1K |
|
|
PHX
3361
DELISTED
PHX Minerals
PHX
| $954K | ﹤0.01% |
245,255
-766
| -0.3% | -$2.88K |
|
3362
Granite Ridge Resources
GRNT
$649M
| $953K | ﹤0.01% |
+105,599
| New | +$954K |
|
3363
Larimar Therapeutics
LRMR
$438M
| $953K | ﹤0.01% |
230,791
+116,901
| +103% | +$399K |
|
3364
P3 Health Partners
PIII
$42.6M
| $953K | ﹤0.01% |
10,362
+121
| +1% | +$26.2K |
|
3365
Palladyne AI
PDYN
$295M
| $949K | ﹤0.01% |
282,014
-84
| -0% | -$717 |
|
3366
Lakeland Industries
LAKE
$115M
| $948K | ﹤0.01% |
71,335
+517
| +0.7% | +$6.54K |
|
3367
TELA Bio
TELA
$39.7M
| $947K | ﹤0.01% |
82,412
+13,792
| +20% | +$124K |
|
|
PACX
3368
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $947K | ﹤0.01% |
93,416
-16,914
| -15% | -$170K |
|
|
ATCO
3369
DELISTED
Atlas Corp.
ATCO
| $942K | ﹤0.01% |
61,457
+723
| +1% | +$10.9K |
|
|
HIMX
3370
Himax Technologies
HIMX
$2.58B
| $941K | ﹤0.01% |
151,558
+75,291
| +99% | +$479K |
|
3371
Eos Energy Enterprises
EOSE
$1.47B
| $940K | ﹤0.01% |
635,635
+82,250
| +15% | +$107K |
|
3372
Lightspeed Commerce
LSPD
$1.36B
| $940K | ﹤0.01% |
65,808
-331,797
| -83% | -$5.41M |
|
3373
Harvard Bioscience
HBIO
$28M
| $939K | ﹤0.01% |
33,902
+265
| +0.8% | +$6.53K |
|
|
NAGE
3374
Niagen Bioscience
NAGE
$239M
| $938K | ﹤0.01% |
558,849
+5,524
| +1% | +$8.76K |
|
3375
Finward Bancorp
FNWD
$194M
| $931K | ﹤0.01% |
25,719
+2,480
| +11% | +$82.3K |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.